Document is current

Any future updates will be listed below

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

Crossref DOI link: https://doi.org/10.1186/s12885-016-2917-6

Published Online: 2016-11-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark